Mindera Health SkinAtlas™: The Dataset for Dermal Intelligence™
At Mindera Health, we are developing the SkinAtlas™, an expansive repository of skin data. This database is comprised of multiple data streams including molecular data from our dermal biomarker patch, as well as imaging data and patient metadata. The SkinAtlas™ contains samples both from various skin diseases, as well as across time from a single individual. The Mindera Health platform drives the generation of skin data and molecular content, uniquely positioning it to shape an era of skin analytics where the power of AI/machine learning can be applied across sectors (e.g., psoriasis/inflammation, skin cancer, consumer/beauty, microbiome).
The Mindera Health platform is the world’s first scalable technology to extract RNA data for healthcare decision making
The skin is our largest organ and our primary interface with the world. When skin becomes diseased, it can seriously impact both our physical and emotional well-being. It is a dynamic, constantly evolving organ, yet despite significant advances in the scientific understanding of the skin and the characteristic signatures of skin disease, diagnosis largely remains predicated on a subjective visual exam. This may be followed by a skin biopsy and histological examination. Typically, these procedures are known to have poor sensitivity, and in certain cases, such as inflammatory diseases, highly invasive biopsies are not medically justified.
A New Era of Predictive Skin Analytics
Mindera Health has developed a proprietary platform that allows for simple, rapid and painless extraction of RNA from the skin using a dermal biomarker patch. Subsequent Next-Generation Sequencing of the extracted RNA allows Mindera Health scientists to take a genetic and transcriptomic snapshot of the skin at the exact moment of the test. This rich patient-specific data set is then analyzed by machine learning algorithms to ask sophisticated questions of the data, for example, predicting the appropriate biologic drug for a patient prior to therapeutic selection and treatment.
Given the wealth of molecular information that is currently available and the pace at which new data continues to be acquired, the Mindera Health platform allows for a dramatic improvement in how patients are diagnosed and treated.